Agenus Inc
AGEN5.420USD
+0.060+1.12%
交易中 （美東）報價延遲15分鐘
143.97M總市值
虧損本益比TTM
關於 Agenus Inc 公司
Agenus Inc. 是一家免疫腫瘤學 (IO) 公司，專注於癌症和傳染病，擁有一系列免疫藥物。該公司專門開發激活人體免疫系統對抗癌症和感染的療法。其產品線包括免疫調節抗體、過繼細胞療法（通過 MiNK Therapeutics, Inc.）和疫苗佐劑（通過 SaponiQx, Inc.）。其主要關注點是免疫腫瘤學，其多樣化的產品線由其內部能力支持，包括現行良好生產規範 (cGMP) 製造和臨牀運營平臺。其最先進的抗體候選藥物是 botensilimab（一種多功能免疫細胞激活劑和人類 Fc 增強細胞毒性 T 淋巴細胞抗原 4 (CTLA-4) 阻斷抗體 (AGEN1811)）和 balstilimab（一種程序性死亡受體-1 (PD-1) 阻斷抗體）。其產品線包括幾類免疫療法：檢查點抑制劑、免疫激活劑和腫瘤微環境調節劑。
公司簡介
公司代碼AGEN
公司名稱Agenus Inc
上市日期Feb 04, 2000
CEODr. Garo H. Armen, Ph.D.
員工數量316
證券類型Ordinary Share
年結日Feb 04
公司地址3 Forbes Rd
城市LEXINGTON
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編02421-7305
電話17816744400
網址https://agenusbio.com/
公司代碼AGEN
上市日期Feb 04, 2000
CEODr. Garo H. Armen, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Ms. Christine M. Klaskin
Ms. Christine M. Klaskin
Vice President - Finance
Vice President - Finance
23.48K
+205.07%
Mr. Thomas L. (Tom) Harrison
Mr. Thomas L. (Tom) Harrison
Independent Director
Independent Director
16.30K
+83.18%
Ms. Susan B. Hirsch
Ms. Susan B. Hirsch
Independent Director
Independent Director
5.94K
--
Mr. Brian J. Corvese
Mr. Brian J. Corvese
Independent Director
Independent Director
4.60K
--
Mr. Timothy R. (Tim) Wright
Mr. Timothy R. (Tim) Wright
Lead Independent Director
Lead Independent Director
2.77K
--
Dr. Garo H. Armen, Ph.D.
Dr. Garo H. Armen, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Richard Goldberg
Mr. Richard Goldberg
Chief Development Officer
Chief Development Officer
--
--
Dr. Steven O'Day, M.D.
Dr. Steven O'Day, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Jennifer S. Buell, Ph.D.
Dr. Jennifer S. Buell, Ph.D.
Director
Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Ms. Christine M. Klaskin
Ms. Christine M. Klaskin
Vice President - Finance
Vice President - Finance
23.48K
+205.07%
Mr. Thomas L. (Tom) Harrison
Mr. Thomas L. (Tom) Harrison
Independent Director
Independent Director
16.30K
+83.18%
Ms. Susan B. Hirsch
Ms. Susan B. Hirsch
Independent Director
Independent Director
5.94K
--
Mr. Brian J. Corvese
Mr. Brian J. Corvese
Independent Director
Independent Director
4.60K
--
Mr. Timothy R. (Tim) Wright
Mr. Timothy R. (Tim) Wright
Lead Independent Director
Lead Independent Director
2.77K
--
Dr. Garo H. Armen, Ph.D.
Dr. Garo H. Armen, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Non-cash royalty revenue
23.56M
97.88%
Other services
510.00K
2.12%
地區USD
名稱
營收
佔比
United States
23.56M
97.88%
Rest of world
510.00K
2.12%
業務
地區
業務USD
名稱
營收
佔比
Non-cash royalty revenue
23.56M
97.88%
Other services
510.00K
2.12%
股東統計
更新時間: 7月10日 週四
更新時間: 7月10日 週四
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
9.24%
BlackRock Institutional Trust Company, N.A.
5.86%
B. Riley Financial, Inc
2.76%
Geode Capital Management, L.L.C.
1.98%
Invus Public Equities Advisors, LLC
1.82%
Other
78.33%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
9.24%
BlackRock Institutional Trust Company, N.A.
5.86%
B. Riley Financial, Inc
2.76%
Geode Capital Management, L.L.C.
1.98%
Invus Public Equities Advisors, LLC
1.82%
Other
78.33%
股東類型
持股股東
佔比
Investment Advisor
23.00%
Investment Advisor/Hedge Fund
7.24%
Research Firm
2.79%
Individual Investor
1.94%
Pension Fund
0.59%
Bank and Trust
0.11%
Family Office
0.10%
Hedge Fund
0.05%
Other
64.18%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
332
9.76M
35.62%
-3.10M
2025Q1
345
9.68M
35.51%
-3.04M
2024Q4
351
8.87M
37.81%
-3.86M
2024Q3
360
8.97M
41.48%
-3.09M
2024Q2
356
9.47M
44.86%
-4.33M
2024Q1
365
10.95M
52.48%
-2.79M
2023Q4
382
11.94M
62.90%
-111.48K
2023Q3
392
12.65M
70.00%
-689.92K
2023Q2
391
12.38M
73.61%
-974.75K
2023Q1
387
12.07M
75.08%
+236.97K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
2.55M
9.3%
+140.69K
+5.84%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.61M
5.86%
+103.10K
+6.85%
Mar 31, 2025
B. Riley Financial, Inc
756.96K
2.76%
+756.96K
--
Dec 31, 2024
Geode Capital Management, L.L.C.
544.14K
1.98%
+68.55K
+14.41%
Mar 31, 2025
Invus Public Equities Advisors, LLC
500.00K
1.82%
+500.00K
--
Mar 31, 2025
State Street Global Advisors (US)
480.75K
1.75%
-5.96K
-1.23%
Mar 31, 2025
AQR Capital Management, LLC
441.49K
1.61%
+427.60K
+3080.28%
Mar 31, 2025
Morgan Stanley & Co. LLC
369.40K
1.35%
+34.14K
+10.18%
Mar 31, 2025
Armen (Garo H.)
319.09K
1.16%
+68.31K
+27.24%
Jun 27, 2025
BofA Global Research (US)
200.35K
0.73%
+93.23K
+87.03%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.03%
iShares Russell 2000 Growth ETF
0%
SPDR S&P Biotech ETF
0%
iShares Russell 3000 ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
Fidelity Enhanced Small Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Schwab U.S. Small-Cap ETF
0%
SPDR Portfolio MSCI Global Stock Market ETF
0%
Global X Russell 2000 ETF
0%
查看更多
iShares Micro-Cap ETF
佔比0.03%
iShares Russell 2000 Growth ETF
佔比0%
SPDR S&P Biotech ETF
佔比0%
iShares Russell 3000 ETF
佔比0%
Invesco NASDAQ Future Gen 200 ETF
佔比0%
Fidelity Enhanced Small Cap ETF
佔比0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%
Schwab U.S. Small-Cap ETF
佔比0%
SPDR Portfolio MSCI Global Stock Market ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Feb 15, 2024
Merger
20<1
Feb 15, 2024
Merger
20<1
Feb 15, 2024
Merger
20<1
Feb 15, 2024
Merger
20<1
公告日期
類型
比率
Feb 15, 2024
Merger
20<1
Feb 15, 2024
Merger
20<1
Feb 15, 2024
Merger
20<1
Feb 15, 2024
Merger
20<1
